The PepT1–NOD2 Signaling Pathway Aggravates Induced Colitis in Mice

Slides:



Advertisements
Similar presentations
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Advertisements

Volume 131, Issue 4, Pages (October 2006)
Volume 136, Issue 2, Pages e5 (February 2009)
Serotonin Has a Key Role in Pathogenesis of Experimental Colitis
Volume 139, Issue 2, Pages (August 2010)
Volume 140, Issue 2, Pages e2 (February 2011)
Volume 133, Issue 5, Pages (November 2007)
Volume 138, Issue 3, Pages e2 (March 2010)
Activation of Pattern Recognition Receptors Up-Regulates Metallothioneins, Thereby Increasing Intracellular Accumulation of Zinc, Autophagy, and Bacterial.
Volume 42, Issue 4, Pages (April 2015)
Volume 137, Issue 4, Pages e2 (October 2009)
Volume 134, Issue 5, Pages (May 2008)
Volume 138, Issue 4, Pages (April 2010)
Volume 138, Issue 3, Pages e4 (March 2010)
Volume 131, Issue 4, Pages (October 2006)
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 145, Issue 2, Pages e10 (August 2013)
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Volume 25, Issue 4, Pages (April 2014)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 145, Issue 2, Pages e10 (August 2013)
Volume 137, Issue 5, Pages e1 (November 2009)
Volume 132, Issue 4, Pages (April 2007)
Volume 144, Issue 5, Pages e6 (May 2013)
Volume 137, Issue 3, Pages (September 2009)
Volume 138, Issue 4, Pages e3 (April 2010)
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Volume 141, Issue 4, Pages (October 2011)
Mitochondrial Gene Polymorphisms That Protect Mice From Colitis
Volume 136, Issue 2, Pages (February 2009)
Volume 134, Issue 1, Pages (January 2008)
Volume 130, Issue 2, Pages (February 2006)
Volume 141, Issue 1, Pages (July 2011)
Volume 135, Issue 6, Pages e7 (December 2008)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 140, Issue 3, Pages (March 2011)
Volume 132, Issue 5, Pages (May 2007)
Volume 142, Issue 4, Pages e2 (April 2012)
Volume 125, Issue 6, Pages (December 2003)
Volume 125, Issue 6, Pages (December 2003)
This Month in Gastroenterology
Volume 134, Issue 7, Pages e3 (June 2008)
Volume 143, Issue 4, Pages e4 (October 2012)
Volume 129, Issue 3, Pages (September 2005)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Qinglan Zhao, Yi Wei, Stephen J. Pandol, Lingyin Li, Aida Habtezion 
Volume 129, Issue 6, Pages (December 2005)
Volume 19, Issue 13, Pages (June 2017)
Volume 146, Issue 7, Pages e4 (June 2014)
Covering the Cover Gastroenterology
Volume 135, Issue 5, Pages e5 (November 2008)
A2B Adenosine Receptor Gene Deletion Attenuates Murine Colitis
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 150, Issue 7, Pages (June 2016)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 132, Issue 3, Pages (March 2007)
Leptin: A pivotal mediator of intestinal inflammation in mice
Volume 139, Issue 4, Pages (October 2010)
Volume 25, Issue 7, Pages (July 2017)
Volume 141, Issue 3, Pages (September 2011)
Volume 140, Issue 1, Pages (January 2011)
Volume 132, Issue 2, Pages (February 2007)
Volume 139, Issue 2, Pages (August 2010)
Volume 131, Issue 2, Pages (August 2006)
Volume 140, Issue 4, Pages (April 2011)
Volume 136, Issue 7, Pages (June 2009)
Volume 120, Issue 4, Pages (March 2001)
Lei He, Min Zhou, Yan Chun Li
Presentation transcript:

The PepT1–NOD2 Signaling Pathway Aggravates Induced Colitis in Mice Guillaume Dalmasso, Hang Thi Thu Nguyen, Sarah A. Ingersoll, Saravanan Ayyadurai, Hamed Laroui, Moiz A. Charania, Yutao Yan, Shanthi V. Sitaraman, Didier Merlin  Gastroenterology  Volume 141, Issue 4, Pages 1334-1345 (October 2011) DOI: 10.1053/j.gastro.2011.06.080 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 hPepT1 overexpression increases the susceptibility of mice to DSS-induced colitis. (A) Characterization of β-actin–hPepT1 mice. Western blotting analysis showing hPepT1 expression in tissues of WT and β-actin–hPepT1 animals (A). (i and ii) hPepT1 expression in colonic brush-border membrane vesicles of WT and β-actin–hPepT1 animals. (iii) Immunohistochemical analysis of hPepT1 using colonic sections from WT and β-actin–hPepT1 animals. (iv) hPepT1-mediated uptake of KPV by colonic brush-border membrane vesicles isolated from β-actin–hPepT1mice. (B–F) Sex- and age-matched WT and β-actin–hPepT1 littermates were given water (H2O) or 3% (wt/vol) DSS (DSS) for 8 days. (B) The percentage change in body weight, clinical score, and colon length were assessed at day 8 after treatment. (C) Representative photographs obtained by endoscopy on the day of death. Histologic score assessed at the end of DSS treatment. Representative H&E-stained distal colonic sections are shown. (D) Bars = 100 μm. (E) Neutrophil infiltration into the colon was quantified by the measurement of MPO activity. (F) Levels of colonic cytokine/chemokine mRNA measured by quantitative reverse-transcription polymerase chain reaction. Data are means ± standard error of the mean (n = 9/group/condition) from 2 experiments that yielded similar results (*P < .05; **P < .005). Gastroenterology 2011 141, 1334-1345DOI: (10.1053/j.gastro.2011.06.080) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 hPepT1 overexpression increases the susceptibility of mice to TNBS-induced colitis. WT and β-actin–hPepT1 mice were given intrarectal water (vehicle) or TNBS dissolved in 50% (vol/vol) ethanol. Mice were killed 2 days after treatment. Percentage changes in body weight of β-actin–hPepT1 mice animals during treatment (*P < .05; **P < .005) vs WT-TNBS animals. (A) Clinical scores were assessed on the day of death. (B) Representative photographs were obtained by endoscopy on the day of death. Bars = 100 μm. (C) Representative H&E-stained distal colonic sections and histologic scores assessed on the day of death. (D) Levels of cytokine/chemokine mRNA as determined by quantitative reverse-transcription polymerase chain reaction in the colons of control and TNBS-treated mice. Data are means ± standard error of the mean (n = 9/group/condition) from 2 experiments that yielded similar results (*P < .05; **P < .005; ***P < .001). Gastroenterology 2011 141, 1334-1345DOI: (10.1053/j.gastro.2011.06.080) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 hPepT1 expression in IECs and in immune cells may play an important role in the proinflammatory response. Bone marrow transplants were performed (D, donor; R, recipient). (A) Reverse-transcription polymerase chain reaction and (B) Western blotting analyses confirmed hPepT1 expression in bone marrow in mice receiving hPepT1 mouse-derived marrow. Mice were given intrarectal TNBS dissolved in 50% (vol/vol) ethanol, and were killed 2 days after treatment. (C) Levels of colonic mRNAs encoding cytokines/chemokines were quantified by quantitative reverse-transcription polymerase chain reaction in the colons of control and TNBS-treated mice. Data are means ± standard error of the mean (n = 9/group/condition) from 2 experiments that yielded similar results (*P < .05). Gastroenterology 2011 141, 1334-1345DOI: (10.1053/j.gastro.2011.06.080) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 IEC-specific hPepT1 overexpression increases the susceptibility of mice to DSS-induced colitis. (A) Characterization of villin-hPepT1 mice. (i) IEC-specific hPepT1 expression in villin-hPepT1 mice, but not in WT animals, shown by Western blotting. (ii) hPepT1 expression in colonic brush-border membrane vesicles prepared from WT or villin-hPepT1 mice. (iii) hPepT1 expression assessed by immunohistochemical analysis of colonic sections of WT and villin-hPepT1 animals. (iv) hPepT1 mediated KPV transport in colonic brush-border membrane vesicles prepared from villin-hPepT1 but not in WT mice. (B–F) Sex- and age-matched WT and villin-hPepT1 littermates were given water (H2O) or 3% (wt/vol) DSS (DSS) for 8 days. (B) The percentage change in body weight, clinical score, and colon length were assessed at day 8 after treatment. (C) Representative photographs obtained by endoscopy on the day of death. Histologic score was assessed at the end of DSS treatment. (D) Representative H&E-stained distal colonic sections are shown. Bars =100 μm. (E) Neutrophil infiltration into the colon quantified by measurement of MPO activity. (F) Levels of colonic mRNAs encoding cytokines/chemokines, as determined by quantitative reverse-transcription polymerase chain reaction. Data are means ± standard error of the mean (n = 9/group/condition) from 2 experiments that yielded similar results (*P < .05; **P < .005; ***P < .001). Gastroenterology 2011 141, 1334-1345DOI: (10.1053/j.gastro.2011.06.080) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 IEC-specific hPepT1 overexpression does not increase the susceptibility of mice to TNBS-induced colitis. WT and villin-hPepT1 mice were given intrarectal water (control) or TNBS dissolved in 50% (vol/vol) ethanol. Mice were killed 2 days after treatment. (A) The percentage change in body weight during treatment. (B) Clinical score on the day of death. (C) Representative photographs obtained by endoscopy on the day of death. (D) Representative H&E-stained distal colonic sections and histologic scores assessed on the day of death. (E) Levels of mRNAs encoding cytokines/chemokines (as determined by quantitative reverse-transcription polymerase chain reaction) in the colons of control and TNBS-treated mice. Data are means ± standard error of the mean (n = 9/group/condition) from 2 experiments that yielded similar results. NS, not statistically significant. Gastroenterology 2011 141, 1334-1345DOI: (10.1053/j.gastro.2011.06.080) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 hPepT1 overexpression that increases the susceptibility of mice to DSS-induced colitis requires the presence of bacterial flora. WT and β-actin–hPepT1 mice were treated with broad-spectrum antibiotics. (A) Cultivable bacteria present in the feces before (pretreatment) and after treatment (with antibiotics), and in water (vehicle)-treated mice, were counted. (B) After antibiotic treatment, β-actin–hPepT1 and WT mice were given water or a 3% (wt/vol) DSS solution for 8 days and the levels of colonic mRNAs encoding cytokines/chemokines were measured by quantitative reverse-transcription polymerase chain reaction. Data are means ± standard error of the mean (n = 9/group/condition) from 2 experiments that yielded similar results (*P < .05; **P < .005; ***P < .001 vs water). NS, not statically significant. Gastroenterology 2011 141, 1334-1345DOI: (10.1053/j.gastro.2011.06.080) Copyright © 2011 AGA Institute Terms and Conditions

Figure 7 NOD2 expression increases the severity of colitis in hPepT1 transgenic mice. (A–C) Nod2−/− and β-actin–hPepT1 Tg/Nod2−/− mice were given water (control) or a 3% (wt/vol) DSS solution for 7 days. (A) The percentage change in body weight, assessed at day 7 after treatment. (B) Representative H&E-stained distal colonic sections are shown. Bars = 100 μm. (C) Levels of colonic mRNAs encoding cytokines/chemokines were analyzed by quantitative reverse-transcription polymerase chain reaction. (D–F) Nod2−/− and villin-hPepT1 Tg/Nod2−/− mice were given water (control) or 3% (wt/vol) DSS solution for 7 days. (D) The percentage change in body weight, assessed at day 7 after treatment. (E) Representative H&E-stained distal colonic sections are shown. Bars =100 mm. (F) Levels of colonic mRNA encoding cytokines/chemokines were analyzed by quantitative reverse-transcription polymerase chain reaction. Data are means ± standard error of the mean (n = 9/group/condition); the experiment was repeated twice with similar results (*P < .05; **P < .005; ***P < .001). Gastroenterology 2011 141, 1334-1345DOI: (10.1053/j.gastro.2011.06.080) Copyright © 2011 AGA Institute Terms and Conditions